Published in Int J Radiat Biol on July 01, 1997
MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer. Cancer Res (2010) 1.44
Genotypic characteristics of resistant tumors to pre-operative ionizing radiation in rectal cancer. World J Gastrointest Oncol (2014) 0.77
Higher Initial DNA Damage and Persistent Cell Cycle Arrest after Carbon Ion Irradiation Compared to X-irradiation in Prostate and Colon Cancer Cells. Front Oncol (2016) 0.76
Biology and management of bladder cancer. N Engl J Med (1990) 2.60
Predictors of laparoscopic complications after formal training in laparoscopic surgery. JAMA (1993) 2.37
Organization of the ribosomal ribonucleic acid genes in various wild-type strains and wild-collected strains of Neurospora. Mol Gen Genet (1984) 2.35
Temporal and tissue-specific expression of mouse ets genes. Proc Natl Acad Sci U S A (1987) 2.20
Modulation of HIV-like particle assembly in vitro by inositol phosphates. Proc Natl Acad Sci U S A (2001) 2.07
Prostate cancer in Victoria in 1993: patterns of reported management. Med J Aust (2000) 2.00
Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1. Proc Natl Acad Sci U S A (1990) 1.96
Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer. Oncogene (1999) 1.75
Cyclophosphamide treatment of renal disease in (NZB x NZW) F1 hybrid mice. Lancet (1968) 1.70
The ets gene family. Cell Growth Differ (1992) 1.67
Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation. Oncogene (1990) 1.65
Expression of ets genes in mouse thymocyte subsets and T cells. J Immunol (1989) 1.65
Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology (2000) 1.62
Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc Natl Acad Sci U S A (2001) 1.58
Correction of the NMR structure of the ETS1/DNA complex. J Biomol NMR (1997) 1.50
Mutants of Azotobacter vinelandii unable to fix nitrogen. Biochim Biophys Acta (1969) 1.44
The efficacy of treatment for malignant epidural spinal cord compression. Australas Radiol (1997) 1.43
Differential DNA methylation during the vegetative life cycle of Neurospora crassa. J Bacteriol (1987) 1.31
Characterization and localization of the products of the human homologs of the v-ets oncogene. Oncogene (1988) 1.31
Thymus-derived cells as killer cells in cell-mediated immunity. Transplant Proc (1971) 1.29
Universal immuno-PCR for ultra-sensitive target protein detection. Nucleic Acids Res (1993) 1.27
A short-lived nuclear phosphoprotein encoded by the human ets-2 proto-oncogene is stabilized by activation of protein kinase C. Mol Cell Biol (1988) 1.23
Neurospora crassa cytoplasmic ribosomes: isolation and characterization of a cold-sensitive mutant defective in ribosome biosynthesis. J Bacteriol (1974) 1.23
Energy-linked nicotinamide adenine dinucleotide transhydrogenase in membrane particles from Escherchia coli. Biochim Biophys Acta (1971) 1.22
BIAcore for macromolecular interaction. Curr Opin Biotechnol (1998) 1.22
Age-related response to lidocaine-prilocaine (EMLA) emulsion and effect of music distraction on the pain of intravenous cannulation. Pediatrics (1994) 1.19
On kinetic treatments of enzyme-antienzyme reactions. Biochim Biophys Acta (1970) 1.18
The solution structure of the human ETS1-DNA complex reveals a novel mode of binding and true side chain intercalation. Cell (1995) 1.16
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression. Br J Cancer (2010) 1.16
Measurement of exocytosis by amperometry in adrenal chromaffin cells: effects of clostridial neurotoxins and activation of protein kinase C on fusion pore kinetics. Biochimie (2000) 1.14
Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials (2004) 1.13
Coupling of oscillatory activity between muscles is strikingly reduced in a deafferented subject compared with normal controls. J Neurophysiol (2004) 1.13
Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization. Mol Cell Biol (2001) 1.12
Optimization of primer sequences for mouse scFv repertoire display library construction. Nucleic Acids Res (1994) 1.11
Phosphorylation of the ETS-2 protein: regulation by the T-cell antigen receptor-CD3 complex. Mol Cell Biol (1990) 1.11
Methods for DNA extraction from Candida albicans. Anal Biochem (1987) 1.10
Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene. Biochim Biophys Acta (1998) 1.09
Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides. Cancer Res (1997) 1.07
Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets. Int J Cancer (2000) 1.07
Chemical cleavage at aspartyl residues for protein identification. Anal Chem (2001) 1.06
Paraffin section storage and immunohistochemistry. Effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigen. Appl Immunohistochem Mol Morphol (2000) 1.06
Different levels of DNA methylation in yeast and mycelial forms of Candida albicans. J Bacteriol (1987) 1.05
Knee muscular response strategies differ by developmental level but not gender during jump landing. Electromyogr Clin Neurophysiol (2004) 1.05
Human ERG-2 protein is a phosphorylated DNA-binding protein--a distinct member of the ets family. Oncogene (1993) 1.04
Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers. Clin Cancer Res (1997) 1.04
The early antibody-forming response to Salmonella antigens. A study of morphology and kinetics in vivo and in vitro. Immunology (1970) 1.03
Differentation of foetal mouse thymus. Ultrastructure of organ cultures and of subcapsular grafts. Immunology (1971) 1.02
Molecular and traditional chemotherapy: a united front against prostate cancer. Cancer Lett (2010) 1.02
Magnification of rRNA gene number in a Neurospora crassa strain with a partial deletion of the nucleolus organizer. Chromosoma (1986) 1.00
Regulation of ribosomal RNA cistron number in a strain of Neurospora crassa with a duplication of the nucleolus organizer region. Biochim Biophys Acta (1982) 0.98
Split-course accelerated therapy in head and neck cancer: an analysis of toxicity. Int J Radiat Oncol Biol Phys (1995) 0.98
Laparoscopic surgical training: effectiveness and impact on urological surgical practice patterns. J Urol (1993) 0.97
Comparison between the clonogenic, MTT, and SRB assays for determining radiosensitivity in a panel of human bladder cancer cell lines and a ureteral cell line. Radiat Oncol Investig (1999) 0.97
Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines. Prostate Cancer Prostatic Dis (2003) 0.96
Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines. Cancer Lett (2000) 0.96
Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by magnetic resonance imaging and treated with curative intent. Int J Gynecol Cancer (2008) 0.96
An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4 integrin gene promoter. J Biol Chem (1994) 0.96
Neurospora crassa cytoplasmic ribosomes; ribosomal ribonucleic acid synthesis in the wild type. J Bacteriol (1976) 0.95
A new senescence-inducing mitochondrial linear plasmid in field-isolated Neurospora crassa strains from India. Curr Genet (1991) 0.94
Higher expression of oncoproteins c-myc, c-erb B-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors. Ann Surg Oncol (1996) 0.93
The development of a treatment protocol for patients with chronic radiation-induced rectal bleeding. Aust N Z J Surg (1996) 0.93
Structural inferences of the ETS1 DNA-binding domain determined by mutational analysis. Oncogene (1994) 0.92
Genomic alterations (LOH, MI) on chromosome 17q21-23 and prognosis of sporadic colorectal cancer. Int J Cancer (2000) 0.92
Refolding proteins by gel filtration chromatography. FEBS Lett (1994) 0.92
Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models. Gene Ther (2002) 0.91
Studies of peritoneal macrophage function in mice with systemic lupus erythematosus: depressed phagocytosis of opsonized sheep erythrocytes in vitro. Clin Immunol Immunopathol (1983) 0.91
Ewing's sarcoma: long-term follow-up in 49 patients treated from 1967 to 1989. Int J Radiat Oncol Biol Phys (1993) 0.91
Isoenzymes of adenylate kinase in human tissue. Biochim Biophys Acta (1972) 0.91
Energy-linked and energy-independent transhydrogenase activities in Escherichia coli vesicles. Biochim Biophys Acta (1975) 0.90
Failure to transfer haemolytic anaemia or glomerulonephritis with cell-free material from NZB mice. Clin Exp Immunol (1970) 0.90
Influence of training on biomechanics of wheelchair propulsion. J Rehabil Res Dev (2001) 0.90
Is a Klebsiella plasmid involved in the aetiology of Ankylosing Spondylitis in HLA-B27-positive individuals? Mol Immunol (1983) 0.89
The ets family of genes: molecular biology and functional implications. Curr Top Microbiol Immunol (1989) 0.89
c-Ets-1 protein is hyperphosphorylated during mitosis. Oncogene (1993) 0.89
ETS family of genes in leukemia and Down syndrome. Am J Med Genet Suppl (1990) 0.89
Bladder cancer xenografts: a model of tumor cell heterogeneity. Cancer Res (1986) 0.89
Monoclonal antibodies specific to human ETS-2 oncoprotein: recognition of epitopes clustered on the B domain. Hybridoma (1990) 0.88
Cyclophosphamide treatment of kidney disease in (NZB x NZW) F1 mice. Lancet (1966) 0.88
Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression. Oncol Res (1998) 0.87
ets-1 in astrocytes: expression and transmitter-evoked phosphorylation. Mol Cell Biol (1995) 0.87
Control of membrane fusion dynamics during regulated exocytosis. Biochem Soc Trans (2001) 0.87
Adenylate kinase from bakers' yeast. IV. Substrate and inhibitor structurll requirements. J Biol Chem (1970) 0.87
Relative efficiency of tumor cell killing in vitro by two enzyme-prodrug systems delivered by identical adenovirus vectors. Clin Cancer Res (1997) 0.87
Initial intravenous cis-platinum therapy: improved management for invasive high risk bladder cancer? J Urol (1985) 0.86
Inverse correlation between KAI1 mRNA levels and invasive behaviour in bladder cancer cell lines. Cancer Lett (2000) 0.86
Neurospora crassa cytoplasmic ribosomes: cold-sensitive mutant defective in ribosomal ribonucleic acid synthesis. J Bacteriol (1976) 0.86
Purification of kinases by general ligand affinity chromatography. Arch Biochem Biophys (1977) 0.86
The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy: a double-blind, randomized trial. Int J Radiat Oncol Biol Phys (2001) 0.85
Elemental sulfur: a novel inhibitor of adenylate kinase. Biochem Biophys Res Commun (1983) 0.85
Protein markers in colorectal cancer: predictors of liver metastasis. Ann Surg (1999) 0.85
Vascular endothelial growth factor expression is reduced in liver metastasis from colorectal cancer and correlates with urokinase-type plasminogen activator. Anticancer Res (1998) 0.84
A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1. Genomics (2001) 0.84
Analysis of human immunodeficiency virus type 1 containing HERV-K protease. AIDS Res Hum Retroviruses (2000) 0.84